medigraphic.com

2016, Number S3

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2016; 54 (S3)

Adverse events during diagnostic and therapeutic pediatric cardiac catheterization

Zepeda-Arámbula A, Gutiérrez-Cobian L, Villatoro-Fernández JL, Pacheco-López SL, Tlacuilo-Parra A

Language: Spanish
References: 18
Page: 276-283
PDF size: 310.11 Kb.


ABSTRACT

Background: The aim of this paper is to determine the frequency of adverse events during heart catheterization, in both categories diagnostic and therapeutic procedures in children.
Methods: We review the clinical charts of those patients undergoing heart catheterization during the period from May 1 to October 31, 2014, in order to determine the frequency of adverse events presented within the first 24 hours after the procedure.
Results: During the six month period, 143 procedures were performed, of which 126 met the inclusion criteria. According to the type of procedure we divide it in: diagnostic 68 (54%) and therapeutic 58 (46%). Adverse effects were developed in 16 patients (13%), 11.7% during diagnostic and 14% within the therapeutic procedures. The adverse events were classified as serious in 7 (5.5%), endangering the live in 5 (3.9%) and catastrophic in only one (0.79%). Those factors associated with the development of an adverse event were: age less than one year-old (OR = 5.45), unscheduled admission to the procedure (OR = 1.2) and use of inotropic drugs (OR = 7).
Conclusions: Cardiac catheterization performed in our facility is a safe procedure, with a percentage of adverse events similar to that reported worldwide. It is essential to make a proper and comprehensive assessment of the patient before the procedure, considering stratification according to risk categories and assessing the state of gravity of the children.


REFERENCES

  1. Instituto Nacional de Estadística y Geografía. Tasa bruta de natalidad 2013 (base de datos por línea). México: Censo de población 2010, (actualización 09/02/15; fecha de consulta 05/04/15). Disponible en: www.inegi.org.mx.

  2. Mendieta-Alcántara G, Santiago-Alcántara E, Mendieta- Zerón H, Dorantes-Piña R, Ortiz de Zárate- Alarcón G, Otero-Ojeda GA. Incidencia de las cardiopatías congénitas y los factores asociados a la letalidad en niños nacidos en dos hospitales del Estado de México. Gac Med Mex. 2013;149(6):617-623.

  3. Calderón-Colmenero J, Cervantes-Salazar JL, Curi- Curi PJ, Ramírez-Marroquín S. Problemática de las cardiopatías congénitas en México, propuesta de regionalización. Arch Cardiol Mex. 2010;80(2): 133-140.

  4. Botto L, Goldmuntz E. Epidemiology and Prevention of Congenital Heart Defects; En: Allen H, Driscoll D, Shaddy R (Editores). Moss and Adams. Heart Disease in Infants, Children, and Adolescents: Including the Fetus and Young Adult. 7a ed. Philadelphia: Lippincott Williams and Wilkins; 2008. pp. 525-545.

  5. Sistema Nacional de Información en Salud. (Base de datos en línea). México: Mortalidad 2000-2008 (fecha de actualización 2008; fecha de consulta 14/04/2015). Disponible en: www.sinais.salud.gob.mx.

  6. García Montes JA. Cateterismo diagnóstico en cardiopatías congénitas del adulto. Arch Cardiol Mex. 2006;76(Supl. 2):137-140.

  7. Moreno Martínez FL, Echarte Martínez JC. Indicaciones de cateterismo cardíaco. Cor Salud. 2009;1: 25-36.

  8. Serrano Aísa PJ, Portero Pérez MP, Aguarón López V, Peleato Peleado A, Ferreira Montero IJ. Cateterismo cardíaco y procedimientos intervencionistas. Clin Invest Arterioscl. 2002;14:156-165.

  9. Zabal C. El cateterismo intervencionista en las cardiopatías congénitas. Arch Cardiol Mex. 2001;71: 188-191.

  10. Rashkind WJ, Miller WW. Creation of an atrial septal defect without thoracotomy: palliative approach to complete transposition of the great arteries. JAMA. 1966;196(11):991-992.

  11. Bergersen L, Gauvreau K, Marshall A, Kreutzer J, Beekman R. Procedure-type risk categories for pediatric and congenital cardiac catheterization. Circ Cardiovasc Interv. 2011;4(2):188-194.

  12. Laussen PC, Salvin J. Diagnostic and Therapeutic Cardiac Catheterization. En: Fuhrman BP, Zimmerman JJ. Pediatric Critical Care. 4ta Ed. Philadelphia: Elsevier Saunders; 2011. pp. 266-276.

  13. Bergersen L, Gauvreau K, Foerster SR, Marshall AC, McElhinney DB, Beekman RH, et al. Catheterization for congenital heart disease adjustment for risk method (CHARM). JACC Cardiovasc Interv. 2011;4(9):1038-1046.

  14. Lin CH, Hegde S, Marshall AC, Porras D, Gauvreau K, Balzer DT et al. Incidence and management of lifethreatening adverse events during cardiac catheterization for congenital heart disease. Pediatr Cardiol. 2014;35(1):140-148.

  15. Bergersen L, Marshall A, Gauvreau K, Beekman R, Hirsch R, Foerster S et al. Adverse event rates in congenital cardiac catheterization - a multi-center experience. Catheter Cardiovasc Interv. 2010;75(3): 389-400.

  16. Garcia H, Ramos-Jimenez A, Villegas-Silva R, Rodriguez L, Vera-Canelo M. Post-discharge survival of newborn infants with congenital cardiopathies undergoing heart surgery or interventional catheterization. Rev Invest Clin. 2002;54:311-319.

  17. Zabal-Cerdeira C, Garcia-Montes JA, Sandoval- Jones JP, Calderon-Colmenero J, Patiño-Bahena J, Juanico-Enriquez A, Buendía-Hernandez A. Percutaneous closure of atrial septal defects with the Amplatzer device: 15 years of experience. Arch Cardiol Mex. 2014;84(4):250-255.

  18. Bergersen L, Gauvreau K, McElhinney D, Fenwick S, Kirshner D, Harding J et al. Capture of complexity of specialty care in pediatric cardiology by work RVU. Pediatrics. 2013;131:258-267.




2020     |     www.medigraphic.com